Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line

Oncogene

Volumn 15, Issue 23, 1997, Pages 2867-2875

  Barboule, N ^a   Chadebech, P ^a   Baldin, V ^a   Vidal, S ^a   Valette, A ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Mitotic exit; p21; p34(cdc2) activity; Paclitaxel

Indexed keywords

PACLITAXEL; PROTEIN KINASE; PROTEIN P21;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CELL CYCLE G2 PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031466503     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201469     Document Type: Article

References (45)

1. Andreassen PR and Margolis RL. (1994). J. Cell Biol., 127, 789-802.
2. Barboule N, Mazars P, Baldin V, Vidal S, Jozan S, Martel P and Valette A. (1995). Int. J. Cancer, 63, 611-615.
3. Bhalla K, Ibrado AM, Tourkina E, Tang CQ, Mahoney ME and Huang Y. (1993). Leukemia, 7, 563-568.
4. Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J and Neckers L. (1995). Cancer Res., 55, 4623-4626.
5. Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y and Nisen PD. (1996). Oncogene, 13, 1395-1403.
6. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RJ, Raskind WH and Reid BJ. (1995). Science, 267, 1353-1356.
7. Darzynkiewicz Z, Gong J and Traganos F. (1994). Methods in Cell Biol., 41, 421-435.
8. Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti F, Russo P, Parodi S, D'Incalci M and Broggini M. (1997). Cancer Res., 57, 870-874.
9. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. (1995). Cell, 82, 675-684.
10. Donaldson KL, Goolsby G, Kiener PA and Wahl AF. (1994). Cell Growth & Differ., 5, 1041-1050.
11. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed S. (1994). Cell, 76, 1013-1023.
12. Draetta G and Beach D. (1988). Cell, 54, 17-26.
13. Draetta G. (1990). TIBS, 15, 378-383.
14. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
15. Gartel AL, Serfas MS and Tyner AL. (1996). Proc. Soc. Exp. Biol. Med., 213, 138-149.
16. Gorospe M and Holbrook NJ. (1996). Cancer Res., 56, 475-479
17. Gorospe M, Liu Y, Xu Q, Chrest FJ and Holbrook NJ. (1996). Mol. Cell Biol., 16, 762-770.
18. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. (1995). Mol. Biol. Cell, 6, 387-400.
19. Jiang H, Lin J, Su Z-Z, Collart FR, Huberman E and Fisher PB. (1994). Oncogene, 9, 3397-3406.
20. Jordan MA, Toso R, Thrower D and Wilson L. (1993). Proc. Natl. Acad. Sci. USA, 90, 9552-9556.
21. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H and Wilson L. (1996). Cancer Res., 56, 816-825.
22. Kung AL, Sherwood SW and Schimke RT. (1990). Proc. Natl. Acad. Sci. USA, 87, 9553-9557.
23. Lafon C, Mathieu C, Guerrin M, Pierre O, Vidal S and Valette A. (1996). Cell Growth Differ., 7, 1095-1104.
24. Levedakou EL, Kaufmann WK, Alcorta DA, Galloway DA and Paules RS. (1995). Cancer Res., 55, 2500-2502.
25. Li Y, Jenkins CW, Nichols MA and Xiong Y. (1994). Oncogene, 9, 2261-2268.
26. Liebmann JE, Cook JA, Lipschultz D, Teague D, Fisher J and Mitchell JB. (1993). Br. J. Cancer, 68, 1104-1109.
27. Long BH and Fairchild CR. (1994). Cancer Res., 54, 4355-4361.
28. Mazars P, Barboule N, Baldin V, Vidal S, Ducommun B and Valette A. (1995). FEBS Lett., 362, 295-300.
29. MacLeod KF, Sherry N, Hannon G, Beach D, Tokimo T, Kinzler K, Vogelstein B and Jacks T. (1995). Genes & Dev., 9, 935-944.
30. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR. (1994). Exp. Cell Res., 211, 90-98.
31. Poluha W, Poluha DK, Chang B, Crosbie N, Schonhoff C, Kilpatrick DL and Ross AH. (1996). Mol. Cell Biol., 16, 1335-1341.
32. Polyack K, Waldman T, He T-C, Kinzler KW and Vogelstein B. (1996). Genes & Dev., 10, 1945-1952.
33. Rowinsky EK, Donehower RC, Jones RJ and Tucker RW. (1988). Cancer Res., 48, 4093-4100.
34. Schiff PB, Fant J and Horwiz SB. (1979). Nature, 277, 665-667.
35. Schiff PB, Fant J and Horwiz SB. (1980). Proc. Natl. Acad. Sci. USA, 77, 1561-1565.
36. Shi L, Nishioda WK, Th'ng J, Bradbury EM, Litchfield DW and Greenberg AH. (1994). Science, 263, 1143-1145.
37. Shimizu T, O'Connor PM, Kohn KW and Pommier Y. (1995). Cancer Res., 55, 228-231.
38. Steinman RA, Hoffman B, Iro A, Guillouf C, Lieberman DA and El-Houseini ME. (1994). Oncogene, 9, 3389-3396.
39. Tang C, Willinghan MC, Reed JC, Miyashita T, Ray S, Ponnathpur V, Huang Y, Mahoney ME, Bullock G and Bhalla K. (1994). Leukemia, 8, 1960-1969.
40. Tishler RB, Lamppu DM, Park S and Price BD. (1995). Cancer Res., 55, 6021-6025.
41. Trielli MO, Andreassen PR, Lacroix F and Margolis RL. (1996). J. Cell Biol., 3, 689-700.
42. Waga S, Hannon G, Beach D and Stillman B. (1994). Nature, 369, 574-578.
43. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
44. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW and Galloway DA. (1996). Nature Med., 2, 72-79.
45. Wang J and Walsh K. (1996). Science, 273, 359-361.